Skip to content
Find a Provider
Kenneth Y. Usuki, M.D.

Kenneth Y. Usuki, M.D.

Radiation Oncology , Cancer

4.7 out of 5 stars
145 Ratings
16 Comments
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-2171
Fax (585) 275-1531

Locations

Wilmot Cancer Center - Rochester

Strong Memorial Hospital
90 Crittenden Boulevard
Rochester, NY 14642

(585) 275-5830 Get Directions

About Me

Dr. Kenneth Usuki is a board certified Radiation Oncologist and Associate Professor of Radiation Oncology. He earned his Doctorate of Medicine degree from Jefferson Medical College in Philadelphia, PA. He then went on to complete a surgical/transitional internship at the University of Pennsylvania H...
Dr. Kenneth Usuki is a board certified Radiation Oncologist and Associate Professor of Radiation Oncology. He earned his Doctorate of Medicine degree from Jefferson Medical College in Philadelphia, PA. He then went on to complete a surgical/transitional internship at the University of Pennsylvania Hospital System in Philadelphia, PA, and then residency in Radiation Oncology at the University of Rochester’s Strong Memorial Hospital where he served as chief resident.

Dr. Usuki's primary research and clinical practice includes neuro-oncologic patients with primary malignant brain (glioma, ependymoma, meningioma, and schwannoma)/spine tumors, metastatic lesions to the brain/spine, and benign brain/spine lesions and applying cutting edge radiation treatments such as Stereotactic Radio Surgery (SRS), Brain Lab Cranial Elements SRS, Brain Lab Cranial Multiple Metastases, Intensity Modulated Radiation Therapy (IMRT), VMAT- volumetric-modulated arc therapy, and Image Guided Radiation Therapy (IGRT) with Robotics to the brain and spine. Dr. Usuki serves as the Co-Director of the University of Rochester Spinal Radiosurgery program.

Dr. Usuki also specializes in skin cancers including melanoma, Merkel cell, squamous cell, and basal cell, and utilizes Tomotherapy, VMAT therapy, and electron therapy for the treatment of these diseases. He also treats patients with gastrointestinal tumors including esophagus, rectum, stomach, liver, and pancreas.

Dr. Usuki is heavily involved in the education of residents and medical students at the University of Rochester's School of Medicine and Dentistry. He serves as the Associate Radiation Oncology Residency Director, the Radiation Oncology Medical Student Clerkship Director, and as the Wellness Representative of the Department of Radiation Oncology.

Faculty Appointments

Associate Professor - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Radiation Oncology, University of Rochester Medical Center. 2005 - 2009

Internship, Transitional Year, Penn Presbyterian Medical Center. 2004 - 2005

Education

MD | Jefferson Medical College. 2004

Publications

Journal Articles

How Does the Number of Brain Metastases Correlate With Normal Brain Exposure in Single-Isocenter Multitarget Multifraction Stereotactic Radiosurgery.

Zheng D, Yoon J, Jung H, Lemus OMD, Gou L, Zhou Y, Usuki KY, Hardy S, Milano MT

Advances in radiation oncology.. 2024 June 9 (6):101499. Epub 03/19/2024.

Dosimetric evaluation of LINAC-based single-isocenter multi-target multi-fraction stereotactic radiosurgery with more than 20 targets: comparing MME, HyperArc, and RapidArc.

Jung H, Yoon J, Dona Lemus O, Tanny S, Zhou Y, Milano M, Usuki K, Hardy S, Zheng D

Radiation oncology.. 2024 February 719 (1):19. Epub 02/07/2024.

Cognitive and neuroimaging outcomes in individuals with benign and low-grade brain tumours receiving radiotherapy: a protocol for a prospective cohort study.

Hardy SJ, Finkelstein AJ, Tivarus M, Culakova E, Mohile N, Weber M, Lin E, Zhong J, Usuki K, Schifitto G, Milano M, Janelsins-Benton MC

BMJ open.. 2023 February 1513 (2):e066458. Epub 02/15/2023.

Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001

Gondi V; Deshmukh S; Brown PD; Wefel JS; Armstrong TS; Tome WA; Gilbert MR; Konski A; Robinson CG; Bovi JA; Benzinger TLS; Roberge D; Kundapur V; Kaufman I; Shah S; Usuki KY; Baschnagel AM; Mehta MP; Kachnic LA.

Int J Radiat Oncol Biol Phys. 2023; 117(3): 571-580.

Association of Radiation Dose to the Amygdala-Orbitofrontal Network with Emotion Recognition Task Performance in Patients with Low-Grade and Benign Brain Tumors

Hardy SJ; Finkelstein A; Milano MT; Schifitto G; Sun H; Holley K; Usuki K; Weber MT; Zheng D; Seplaki CL; Janelsins M.

Cancers (Basel). 2023; 15(23): 5544.

A comprehensive evaluation of advanced dose calculation algorithms for brain stereotactic radiosurgery

Yoon J; Jung H; Tanny SM; Lemus OMD; Milano MT; Hardy SJ; Usuki KY; Zheng D.

J Appl Clin Med Phys. 2023; 24(11): e14169.

A comprehensive evaluation of advanced dose calculation algorithms for brain stereotactic radiosurgery

Yoon J; Jung H; Tanny SM; Lemus OMD; Milano MT; Hardy SJ; Usuki KY; Zheng D.

J Appl Clin Med Phys. 2023; 24(11): e14169.

Patterns of recurrence after intracranial stereotactic radiosurgery for brain-only metastases from non-small cell lung cancer and the impact of upfront thoracic therapy with synchronous presentation.

Bergsma DP, Moravan MJ, Suri JS, Cummings MA, Usuki KY, Singh DP, Milano MT

Journal of thoracic disease.. 2022 June 14 (6):1869-1879. Epub 1900 01 01.

New dosimetric guidelines for linear Boltzmann transport equations through comparative evaluation of stereotactic body radiation therapy for lung treatment planning

Webster M; Tanny S; Joyce N; Herman A; Chen Y; Milano M; Usuki K; Constine L; Singh D; Yeo I.

J Appl Clin Med Phys. 2021; 22(12): 115-124.

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, Stea B, Yoon H, Li J, Laack NN, Kruser TJ, Chmura SJ, Shi W, Deshmukh S, Mehta MP, Kachnic LA,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 April 138 (10):1019-1029. Epub 02/14/2020.

Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis.

Milano MT, Bates JE, Budnik J, Qiu H, Hardy S, Cummings MA, Baumgart MA, Maggiore RJ, Mulford DA, Usuki KY

Lung cancer management.. 2020 February 259 (1):LMT25. Epub 02/25/2020.

Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?

Cummings MA, Usuki KY, Fleming FJ, Tejani MA, Katz AW

Journal of gastrointestinal oncology.. 2019 April 10 (2):357-361. Epub 1900 01 01.

SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.

Qiu H, Moravan MJ, Milano MT, Usuki KY, Katz AW

Journal of gastrointestinal cancer.. 2018 December 49 (4):463-469. Epub 1900 01 01.

Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.

Bates JE, Choi G, Usuki KY, Katz AW, Milano MT

American journal of clinical oncology.. 2018 December 41 (12):1172-1175. Epub 1900 01 01.

Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity.

Cummings M, Youn P, Bergsma DP, Usuki KY, Walter K, Sharma M, Okunieff P, Schell MC, Milano MT

Neurosurgery.. 2018 September 183 (3):437-444. Epub 1900 01 01.

Radiation-Induced Edema After Single-Fraction or Multifraction Stereotactic Radiosurgery for Meningioma: A Critical Review.

Milano MT, Sharma M, Soltys SG, Sahgal A, Usuki KY, Saenz JM, Grimm J, El Naqa I

International journal of radiation oncology, biology, physics.. 2018 June 1101 (2):344-357. Epub 03/29/2018.

Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.

Qiu H, Katz AW, Chowdhry AK, Usuki KY, Singh DP, Metcalfe S, Cheruvu P, Chen Y, Okunieff P, Milano MT

American journal of clinical oncology.. 2018 January 41 (1):53-58. Epub 1900 01 01.

Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience.

Bates JE, Youn P, Peterson CR, Usuki KY, Walter KA, Okunieff P, Milano MT

American journal of clinical oncology.. 2017 October 40 (5):439-443. Epub 1900 01 01.

Patterns of Systemic Failure in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain-Only Metastases Treated With Intracranial Stereotactic Radiosurgery (SRS).

Bergsma DP, Moravan MJ, Suri JS, Usuki KY, Singh DP, Milano MT

International journal of radiation oncology, biology, physics.. 2016 October 196 (2S):E421. Epub 1900 01 01.

Clinical Presentation and Distribution of Solitary Brain Metastases Among Non-Small Cell Lung Cancer (NSCLC) Patients in the Modern Staging Era.

Suri JS, Bergsma DP, Moravan MJ, Usuki KY, Milano MT

International journal of radiation oncology, biology, physics.. 2016 October 196 (2S):E477. Epub 1900 01 01.

Stereotactic Radiosurgery for Brain Metastases Using Conservative Dosing Regimen.

Cummings MA, Youn P, Usuki KY, Schell MC, Sharma M, Okunieff P, Milano MT

International journal of radiation oncology, biology, physics.. 2016 October 196 (2S):E71. Epub 1900 01 01.

Repeat courses of SRS in patients initially treated with SRS alone for brain-metastatic melanoma.

Bates JE, Youn P, Usuki KY, Dhakal S, Milano MT

Melanoma management.. 2016 June 3 (2):97-104. Epub 05/25/2016.

Severe radiation-induced leukoencephalopathy: case report and literature review

Cummings M; Dougherty DW; Mohile NA; Walter KA; Usuki KY; Milano MT.

Adv Radiat Oncol. 2016; 1(1): 17-20.

Repeat courses of SRS in patients initially treated with SRS alone for brain-metastatic melanoma

Bates JE; Youn P; Usuki KY; Dhakal S; Milano MT.

Melanoma Management. 2016; 3: 97-104.

Severe radiation-induced leukoencephalopathy: Case report and literature review.

Cummings M, Dougherty DW, Mohile NA, Walter KA, Usuki KY, Milano MT

Advances in radiation oncology.. 2016 1 (1):17-20. Epub 02/02/2016.

Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease.

Bates JE, Youn P, Usuki KY, Walter KA, Huggins CF, Okunieff P, Milano MT

Journal of neuro-oncology.. 2015 November 125 (2):411-8. Epub 09/09/2015.

Local control rates with five fractions of stereotactic body radiotherapy for primary lung tumors: a single institution experience of 153 consecutive patients

Singh D; Chen Y; Bergsma DP; Usuki KY; Dhakal S; Hare MZ; Joyce N; Smudzin T; Rosenzweig D; Schell MC; Milano MT.

Transl Cancer Res. 2015; 4(4): 332-339.

Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung.

Singh D, Chen Y, Hare MZ, Usuki KY, Zhang H, Lundquist T, Joyce N, Schell MC, Milano MT

Journal of thoracic disease.. 2014 April 6 (4):369-74. Epub 1900 01 01.

Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.

Milano MT, Zhang H, Usuki KY, Singh DP, Chen Y

Cancer.. 2012 November 15118 (22):5572-9. Epub 04/27/2012.

Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy: normal tissue dose constraints of the central nervous system.

Milano MT, Usuki KY, Walter KA, Clark D, Schell MC

Cancer treatment reviews.. 2011 November 37 (7):567-78. Epub 05/14/2011.

Age-related Differences in Symptoms and Their Interference with Quality of Life in 903 Cancer Patients Undergoing Radiation Therapy.

Mohile SG, Heckler C, Fan L, Mustian K, Jean-Pierre P, Usuki K, Sprod L, Janelsins M, Purnell J, Peppone L, Palesh O, Devine KA, Morrow G

Journal of geriatric oncology.. 2011 October 2 (4):225-232. Epub 1900 01 01.

An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR

Seminars in oncology.. 2011 June 38 (3):431-8. Epub 1900 01 01.

Polarity Therapy for cancer-related fatigue in patients with breast cancer receiving radiation therapy: a randomized controlled pilot study.

Mustian KM, Roscoe JA, Palesh OG, Sprod LK, Heckler CE, Peppone LJ, Usuki KY, Ling MN, Brasacchio RA, Morrow GR

Integrative cancer therapies.. 2011 March 10 (1):27-37. Epub 03/07/2011.

Polarity therapy for cancer-related fatigue in patients with breast cancer receiving radiation therapy: a randomized controlled pilot study

Mustian KM; Roscoe JA; Palesh OG; Sprod LK; Heckler CE; Peppone LJ; Usuki KY; Ling MN; Brasacchio RA; Morrow GR.

Integrative cancer therapies. 2011; 10(1): 27-37.

Prognostic indicators following ipsilateral tumor recurrence in patients treated with breast-conserving therapy.

Tuli R, Christodouleas J, Roberts L, Deol SJ, Usuki KY, Frassica D, Rosenberg AL

American journal of surgery.. 2009 October 198 (4):557-61. Epub 1900 01 01.

Diagnosis, treatment, and management of breast cancer in previously augmented women.

Tuli R, Flynn RA, Brill KL, Sabol JL, Usuki KY, Rosenberg AL

The breast journal.. 2006 12 (4):343-8. Epub 1900 01 01.

Books

Clinical Radiation Oncology, 4th Edition (2016)

Chapter: Metastatic Disease: Bone, Spinal Cord, Brain, Liver and Lung

Image-Guided Hypofractionated Stereotactic Radiotherapy (IG-hSRT) A Practical Approach to SRT for Brain and Spine Tumor, 1st Edition (2016)

Chapter: Radiation Necrosis

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.7 stars

Likelihood of recommending this care provider to others

4.6 stars

Explanations the care provider gave you about your problem or condition

4.6 stars

Care provider's efforts to include you in decisions about your care

4.7 stars

Concern the care provider showed for your questions or worries

4.6 stars

Patient Comments

5.0 stars

All questions were answered

Dec 16, 2024

4.6 stars

Dr Usuki great doctor

Nov 29, 2024

5.0 stars

Dr. Usuki is not only very knowledgeable, he has been extremely helpful during my health issues.

Nov 24, 2024

5.0 stars

In depth conversation. Made the process more comfortable.

Nov 19, 2024

5.0 stars

Everyone was very caring and kind.

Jul 30, 2024

Dr. Usuki has been wonderful throughout my treatment. I highly recommend Dr. Usuki, The Wilmot Cancer Center and UR Medicine

Jan 15, 2024

1.4 stars

[...] My wife and I both got the feeling that I was an inconvenience to him [...]

Aug 24, 2023

5.0 stars

I live in Fl and come all the way back to New York st and Rochester because of this provider as he is that good I feel.

Jul 17, 2023

5.0 stars

This provider is excellent.

Jul 13, 2023

5.0 stars

Dr. Usuki took time to explain options and potential treatments. I felt very confident with him and the direction of care he recommended.

May 02, 2023